BIOTIE THERAPIES CORP SPONSORED ADR

BITI

Delisted

BITI was delisted on the 10th of June, 2016.

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	1 Fidelity Investments Boston, Massachusetts	$18.5M	+$19.3M	+925,000	New
2	BG 2 Baupost Group Boston, Massachusetts	$17.4M	+$18.2M	+869,643	New
3	3 Franklin Resources San Mateo, California	$5.69M	+$5.94M	+284,723	New
4	VVM 4 Versant Venture Management San Francisco, California	$5.37M	+$5.61M	+268,672	New
5	O 5 OrbiMed New York	$5.37M	+$5.61M	+268,672	New
6	DM 6 Deerfield Management New York	$4.38M	+$4.58M	+219,558	New
7	AC 7 Armistice Capital New York	$3.99M	+$4.17M	+200,000	New
8	8 Adage Capital Partners Boston, Massachusetts	$3.94M	+$4.12M	+197,300	New
9	SFM 9 Sphera Funds Management Tel Aviv, Israel	$3.93M	+$4.11M	+196,800	New
10	FCMI 10 Foresite Capital Management II Larkspur, California	$3.77M	+$3.94M	+188,900	New
11	EC 11 EcoR1 Capital San Francisco, California	$2M	+$2.09M	+100,000	New
12	TAF 12 Tredje AP-fonden Se-111 91 Stockholm, Sweden	$1.74M	+$1.39M	+66,500	New
13	CAM 13 Cormorant Asset Management Boston, Massachusetts	$999K	+$1.04M	+50,000	New
14	DCM 14 DAFNA Capital Management Los Angeles, California	$200K	+$209K	+10,000	New
15	15 SG Americas Securities New York	$160K	+$167K	+8,000	New
16	MIM 16 Monashee Investment Management Boston, Massachusetts	$108K	–	–	–
17	TRCT 17 Tower Research Capital (TRC) New York	$18K	+$18.7K	+898	New
18	18 Morgan Stanley New York	$15K	+$15.3K	+735	New
19	19 UBS Group Zurich, Switzerland	$14K	+$14.2K	+681	New
20	20 Citigroup New York	–	+$209	+10	New